The Era of ADCs in the Treatment of NSCLC
Offered By: HMP Education via YouTube
Course Description
Overview
Explore the evolving landscape of antibody-drug conjugates (ADCs) in non-small cell lung cancer (NSCLC) treatment through this informative 33-minute video. Gain insights into the latest advancements, clinical applications, and potential benefits of ADCs in improving outcomes for NSCLC patients. Delve into the mechanisms of action, efficacy data, and safety profiles of emerging ADC therapies. Understand how these targeted treatments are reshaping the therapeutic approach to NSCLC and their implications for patient care. Healthcare professionals can earn Continuing Medical Education (CME) credits by completing the associated program.
Syllabus
The Era of ADCs in the Treatment of NSCLC
Taught by
HMP Education
Related Courses
Take Your Medicine - The Impact of Drug DevelopmentThe University of Texas at Austin via edX Medicating for Mental Health: Judicious Use of Psychiatric Drugs
Colgate University via edX Introduction to Translational Research: Connecting Scientists and Medical Doctors
Taipei Medical University via FutureLearn よくわかる!iPS細胞 (ga019)
Kyoto University via gacco Drug Development
University of California, San Diego via Coursera